Partial irradiation of the liver

Lawrence, 1995, Hepatic toxicity resulting from cancer treatment, Int J Radiat Oncol Biol Phys, 31, 1237, 10.1016/0360-3016(94)00418-K

Dawson, 2000, Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies, J Clin Oncol, 18, 2210, 10.1200/JCO.2000.18.11.2210

Robertson, 1997, Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers, Int J Radiat Oncol Biol Phys, 37, 325, 10.1016/S0360-3016(96)00528-7

Mohiuddin, 1996, Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer, J Clin Oncol, 14, 722, 10.1200/JCO.1996.14.3.722

Ten Haken, 1997, Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors, Int J Radiat Oncol Biol Phys, 38, 613, 10.1016/S0360-3016(97)00009-6

McGinn, 1998, Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model, J Clin Oncol, 16, 2246, 10.1200/JCO.1998.16.6.2246

Ten Haken, 1993, Use of Veff and iso-NTCP in the implementation of dose escalation protocols, Int J Radiat Oncol Biol Phys, 27, 689, 10.1016/0360-3016(93)90398-F

Austin-Seymour, 1986, Dose volume histogram analysis of liver radiation tolerance, Int J Radiat Oncol Biol Phys, 12, 31, 10.1016/0360-3016(86)90412-8

Matsuura, 1998, The usefulness of radiation therapy for hepatocellular carcinoma, Hepatogastroenterology, 45, 791

Lyman, 1985, Complication probability as assessed from dose-volume histograms, Radiat Res, 8, S13, 10.2307/3583506

Ingold, 1965, Radiation hepatitis, Am J Roentgenol, 93, 200

Poussin-Rosillo, 1976, Hepatic radiation tolerance in Hodgkin's disease patients, Radiology, 121, 461, 10.1148/121.2.461

Russell, 1993, Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the RTOG dose escalating protocol, Int J Radiat Oncol Biol Phys, 27, 117, 10.1016/0360-3016(93)90428-X

Lawrence, 1993, Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer, Oncology, 7, 51

Robertson, 1997, A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers of colorectal liver metastases, Int J Radiat Oncol Biol Phys, 39, 1087, 10.1016/S0360-3016(97)00550-6

Emami, 1991, Tolerance of normal tissue to therapeutic irradiation, Int J Radiat Oncol Biol Phys, 21, 109, 10.1016/0360-3016(91)90171-Y

Seong, 2000, Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization, Int J Radiat Oncol Biol Phys, 47, 1331, 10.1016/S0360-3016(00)00519-8

Cheng, 2000, Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma, Int J Radiat Oncol Biol Phys, 47, 435, 10.1016/S0360-3016(00)00462-4

Ohara, 1996, Clearance of parenchymal tumors following radiotherapy: Analysis of hepatocellular carcinomas treated by proton beams, Radiother Oncol, 41, 233, 10.1016/S0167-8140(96)01839-7

Matsuzaki, 1995, New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma, Intern Med, 34, 302, 10.2169/internalmedicine.34.302

Blomgren, 1995, Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients, Acta Oncol, 34, 861, 10.3109/02841869509127197

Uematsu, 2000, Intrafractional tumor position stability during computed tomography (CT)-guided frameless stereotactic radiation therapy for lung or liver cancers with a fusion of CT and linear accelerator (FOCAL) unit, Int J Radiat Oncol Biol Phys, 48, 443, 10.1016/S0360-3016(00)00619-2

Lawrence, 1992, The use of 3-D dose volume analysis to predict radiation hepatitis, Int J Radiat Oncol Biol Phys, 23, 781, 10.1016/0360-3016(92)90651-W

Kutcher, 1989, Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method, Int J Radiat Oncol Biol Phys, 16, 1623, 10.1016/0360-3016(89)90972-3

Burman, 1991, Fitting of normal tissue tolerance data to an analytic function, Int J Radiat Oncol Biol Phys, 21, 123, 10.1016/0360-3016(91)90172-Z

Ten Haken, 2000, Determination of model parameters for description of radiation induced liver disease, 56, S115

Jackson, 1993, Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation, Med Phys, 20, 613, 10.1118/1.597056

Niemierko, 1993, Modeling of normal tissue response to radiation: The critical volume model, Int J Radiat Oncol Biol Phys, 25, 135, 10.1016/0360-3016(93)90156-P

Yorke, 1993, Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation, Radiother Oncol, 26, 226, 10.1016/0167-8140(93)90264-9

Jackson, 1995, Analysis of clinical complication data for radiation hepatitis using a parallel architecture model, Int J Radiat Oncol Biol Phys, 31, 883, 10.1016/0360-3016(94)00471-4

Kwa, 1998, Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients, Int J Radiat Oncol Biol Phys, 42, 1, 10.1016/S0360-3016(98)00196-5

Balter, 1996, Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing, Int J Radiat Oncol Biol Phys, 36, 167, 10.1016/S0360-3016(96)00275-1

Lujan, 1999, Quantization of setup uncertainties in 3-D dose calculations, Med Phys, 26, 2397, 10.1118/1.598756

Dawson, 2000, The reproducibility of active breathing control (ABC) during liver radiotherapy. Proceedings of the American Society for Therapeutic Radiology and Oncology 42nd Annual Meeting, Int J Radiat Oncol Biol Phys, 48, 165, 10.1016/S0360-3016(00)80124-8